2014 Annual Meeting | HIV, PML, and Cerebral Malaria
| 01:00 PM - 02:45 PM | Abstract |
003 - Delivery of Tenofovir to the Brain by Novel Nano-Vesicles for the Treatment of Neuro-HIV
Eliahu Heldman, PhD |
| 01:00 PM - 02:45 PM | Abstract |
004 - Voxel Based Morphometry Findings in an Irish Cohort of HIV Positive Patients
Patricia McNamara, MD, PhD |
| 01:00 PM - 02:45 PM | Abstract |
005 - Development of a Functional Scale for Progressive Multifocal Leukoencephalopathy: The NIH PML Scale
Gloria Von Geldern, MD, FAAN |
| 01:00 PM - 02:45 PM | Abstract |
006 - Survival of Non-AIDS Progressive Multifocal Leukoencephalopathy
Yuri Hanada |
| 01:00 PM - 02:45 PM | Abstract |
007 - Performance of Cerebrospinal Fluid (CSF) Plasmodium falciparum Histidine-Rich Protein-2 (pfHRP-2) in Prediction of Death in Cerebral Malaria
Kiran Thakur, MD, FAAN |
| Anita Koshy, MD | The institution of Dr. Koshy has received research support from NIH. |
| Kiran Thakur, MD, FAAN | Dr. Thakur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. The institution of Dr. Thakur has received research support from Center for Disease Control and Prevention. |
| Allen J. Aksamit, Jr., MD, FAAN | Dr. Aksamit has nothing to disclose. |
| Daniel Reich, MD, PhD | Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with PeerView. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Biohaven that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sana that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Merck KGaA EMD Serono that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Bristol-Meyers Squibb that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with ChemoCentryx that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Perceptive that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Novartis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities. |
| Avindra Nath, MD, MBBS, FAAN | The institution of Dr. Nath has received research support from National Institutes of Health. The institution of Dr. Nath has received research support from Target ALS. Dr. Nath has received intellectual property interests from a discovery or technology relating to health care. |
| Denise I. Campagnolo, MD, MS | Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen. |
| No disclosure on file | |
| Irene Cortese, MD | Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma. |
| Gloria Von Geldern, MD, FAAN | The institution of Dr. Von Geldern has received research support from Novartis. The institution of Dr. Von Geldern has received research support from Contineum Therapeutics. Dr. Von Geldern has received personal compensation in the range of $0-$499 for serving as a DSMB member with NIH, NINDS. Dr. Von Geldern has a non-compensated relationship as a editorial board member with MS and Related Disorders Journal that is relevant to AAN interests or activities. |
| Peter Bede, MD, PhD | Dr. Bede has nothing to disclose. |
| Patricia McNamara, MD, PhD | No disclosure on file |
| Janice M. Redmond, MD | Dr. Redmond has nothing to disclose. |
| Colin Doherty, MD | The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland. |
| Yuri Hanada | No disclosure on file |
| Joan M. Ohayon | Joan M. Ohayon has nothing to disclose. |
| Eliahu Heldman, PhD | No disclosure on file |
| Irwin Hollander, PhD | No disclosure on file |
| Sarah Naoshy | No disclosure on file |
| Lily Lee, PhD | Dr. Lee has nothing to disclose. |
| Jonathan A. Kendter, PharmD | No disclosure on file |